does medicaid cover glp 1 in michigan π¨PSA for MI recipients interested Wegovy or Zepboundπ¨ Coverage for these medications is changing dramatically starting January 1, 2026. Both Wegovy and Zepbound will no longer be preferred agents on Popular, But Expensive, Weight-Loss Drugs
Description
Future randomised controlled trials should specifically evaluate the effectiveness of novel AOMs for long-term weight management in older adults with obesity, carefully considering the impact on body composition and functional ability, as well as health economics.

The risks have come into sharp focus during the present pandemic
Designed to help manage cravings and support metabolism

Dispense a small amount of VOL
Maybe it's time we rethought our own judgement around obesity treatment
